ENGENE HOLDINGS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.22 USD | -0.38% |
|
-2.94% | +43.23% |
| 15/05 | EnGene Holdings Inc. Approves Board Appointments | CI |
| 22/04 | Wells Fargo Starts enGene Holdings With Overweight Rating, $30 Price Target | MT |
Valuation
| Fiscal Period: October | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | - | 583 | - | - |
| Enterprise Value (EV) 1 | - | 350.5 | 241.4 | 311 |
| P/E ratio | -0.14 x | -10 x | -9.04 x | -8.68 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 22.9 x |
| EV / Revenue | - | - | - | 12.2 x |
| EV / EBITDA | - | -7.82 x | -3.63 x | -3.81 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | 2.42 x | 1.92 x | 2.81 x |
| Nbr of stocks (in thousands) | - | 44,101 | - | - |
| Reference price 2 | 21.70 | 13.22 | 13.22 | 13.22 |
| Announcement Date | 29/01/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: October | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | 25.51 |
| EBITDA 1 | - | -44.81 | -66.47 | -81.63 |
| EBIT 1 | - | -50.87 | -72.71 | -83.19 |
| Operating Margin | - | - | - | -326.15% |
| Earnings before Tax (EBT) 1 | - | -54.13 | -79.07 | -89.51 |
| Net income 1 | -99.92 | -54.09 | -71.1 | -78.71 |
| Net margin | - | - | - | -308.6% |
| EPS 2 | -151.2 | -1.322 | -1.463 | -1.523 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Announcement Date | 29/01/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: October | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - |
| EBITDA 1 | - | -6.515 | -9.095 | -12.76 | - | - |
| EBIT 1 | - | -10.95 | -13.97 | -17.53 | -20.8 | -21.8 |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -13.45 | -16.1 | -19.65 | -20.7 | -21.7 |
| Net income 1 | - | -13.45 | -16.05 | -19.6 | -20.6 | -21.7 |
| Net margin | - | - | - | - | - | - |
| EPS 2 | -0.4600 | -0.2731 | -0.2928 | -0.3545 | -0.6700 | -0.6900 |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 11/03/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: October | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 233 | 342 | 272 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -26.1% | -19.7% | -31.7% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 5.460 | 6.890 | 4.710 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 0.51 | 0.51 | 0.51 |
| Capex / Sales | - | - | - | 1.98% |
| Announcement Date | 29/01/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.22
USD
Average target price
34.4
USD
Spread / Average Target
+160.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +43.23% | 583M | |
| +64.23% | 62.59B | |
| -2.31% | 41.18B | |
| +44.98% | 40.29B | |
| -8.29% | 27.9B | |
| +11.97% | 26.21B | |
| -21.16% | 19.09B | |
| +7.54% | 13.08B | |
| +27.17% | 12.05B | |
| +25.72% | 12.26B |
- Stock Market
- Equities
- ENGN Stock
- Financials enGene Holdings Inc.
